DNA Methylation Profile at the DNMT3L Promoter: A Potential Biomarker for Cervical Cancer

Epigenetics - United States
doi 10.4161/epi.2.2.3692
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Human Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2012English

Promoter DNA Methylation Analysis Reveals a Combined Diagnosis of CpG-based Biomarker for Prostate Cancer

Oncotarget
Oncology
2017English

DNA Methylation: Potential Biomarker in Hepatocellular Carcinoma

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2014English

The Role of Vimentin as a Methylation Biomarker for Early Diagnosis of Cervical Cancer

Molecules and Cells
MedicineCell BiologyMolecular Biology
2011English

Crosstalk Between DNA Methylation and Gene Expression in Colorectal Cancer, a Potential Plasma Biomarker for Tracing This Tumor

Scientific Reports
Multidisciplinary
2020English

A Novel Biomarker for Cervical Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2009English

DNA Methylation as a Universal Biomarker

Expert Review of Molecular Diagnostics
Forensic MedicineGeneticsPathologyMolecular MedicineMolecular Biology
2010English

SLCO4C1 Promoter Methylation Is a Potential Biomarker for Prognosis Associated With Biochemical Recurrence-Free Survival After Radical Prostatectomy

Clinical Epigenetics
GeneticsDevelopmental BiologyMolecular Biology
2019English

PO-296 Elucidating the Potential Role of Cd109 as a Biomarker for Cancer Stem-Like Cells in Cervical Cancer

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy